
Impel Neuropharma (IMPL) Earnings Dates & Reports
Impel Neuropharma (IMPL) Most Recent Earnings
Report DateNov 14, 2023
Period EndingQ3 2023
Est. EPS-$0.36
Actual EPS-$0.58
EarningsMiss
Impel Neuropharma (IMPL) Earnings
View the latest Impel Neuropharma (IMPL) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Impel Neuropharma (IMPL)
Order type
Buy in
Order amount
Est. shares
0 shares
Impel Neuropharma (IMPL) Earnings per Share (EPS) History
Signup for full accessBrowse free
Impel Neuropharma (IMPL) Latest Earnings
The value each IMPL share was expected to gain vs. the value each share gained.
Impel Neuropharma (IMPL) reported its most recent earnings on Nov 14, 2023 for Q3 2023, posting earnings per share (EPS) of -$0.58. This exceeded analysts' expectations of -$0.36 by 61.11%, marking a Miss.
For comparison, Impel Neuropharma reported EPS of -$1.31 in the same quarter last year.
The company is expected to announce its next earnings report on 11/14/2023, with analysts projecting an EPS of $0.
Impel Neuropharma (IMPL) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2023Nov 14, 2023 | -$0.36 | -$0.58 | +61.11% | |
Q2 2023Aug 18, 2023 | -$0.55 | -$0.31 | -43.64% | |
Q1 2023May 12, 2023 | -$0.90 | -$1.27 | +41.11% | |
Q4 2022Mar 24, 2023 | -$1.11 | -$0.97 | -12.61% | |
Q3 2022Nov 14, 2022 | -$1.00 | -$1.31 | +31.00% | |
Impel Neuropharma (IMPL) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Impel Neuropharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 18, 2023 | — | — | — |
May 12, 2023 | — | — | — |
Mar 24, 2023 | — | — | — |
Nov 14, 2022 | — | — | — |
Impel Neuropharma (IMPL) Earnings FAQs
Impel Neuropharma (IMPL) last reported earnings on Nov 14, 2023 for Q3 2023, posting an EPS of -$0.58, which Miss the estimate of -$0.36 by 61.11%.
For Q3 2023, Impel Neuropharma (IMPL) reported an EPS of -$0.58, missing analysts' estimate of -$0.36 by 61.11%.
For Q3 2023, Impel Neuropharma (IMPL) Miss expectations with an actual EPS of -$0.58 vs. an estimated EPS of -$0.36.
Following the last earnings report on Nov 14, 2023, Impel Neuropharma (IMPL)'s stock price moved — from — to —.
The next Impel Neuropharma (IMPL) earnings call is scheduled for Nov. 14, 2023, where executives will discuss financial results and outlook.